Immunoassay Platform
Turn complex biology into actionable, measurable insight.
The Immunoassay Platform provides multiplex immunoassay and ELISA services to support biomedical research across IMCB, A*STAR, academic institutions and external collaborators.
We offer end-to-end assay support, from assay and kit selection to sample preparation, assay execution, data acquisition and basic analysis. Researchers can provide their biological samples and commercially available assay kits, and our team will perform the assay and deliver quantitative results.
Our platform supports a range of biological sample types, including serum, plasma and cell culture supernatants. Depending on the assay and kit requirements, we can also support other biological fluids and matrices, including urine, saliva, tears, cerebrospinal fluid (CSF), milk and lavage fluids.
Key Services
- Luminex multiplex assay service using commercially available Luminex kits
- ELISA assay service
- End-to-end assay support
- Assay and kit selection consultation
- Sample preparation and processing
- Complete assay execution, including incubation, washing and data acquisition
- Quantitative data reporting, including MFI/raw fluorescence data, analyte concentrations and standard curves
Key Applications
- Cytokine and chemokine profiling
- Immune response and inflammation studies
- Biomarker discovery and validation
- Serum/plasma profiling
- Cell culture and stimulation studies
- Cancer and immuno-oncology research
Key Equipment
- Luminex FM3D / LabScan 3D – multiplex bead-based assay platform
- TECAN Plate Washer
- Hidex Sense Microplate Reader
Our People
Key member: Novita
Key leader: John E ConnollyThe Luminex Platform is managed and operated by Novita and scientifically led by Dr. John Edward Connolly, Research Director and Director of the Programme in Translational Immunology at the Institute of Molecular and Cell Biology (IMCB), A*STAR. Dr. Connolly is an internationally recognized immunologist and translational scientist with over two decades of experience in cancer immunotherapy, cell and gene therapy, and translational immunology, supporting the application of multiplex immunoassays for immune profiling, biomarker characterization and translational biomedical research.